COVID-19 as a cause of chronic pulmonary hypertension: pathophysiological rationale and potential of instrumental investigations
Open Access
- 31 August 2021
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (5), 2844
- https://doi.org/10.15829/1728-8800-2021-2844
Abstract
Coronavirus disease 2019 (COVID-19) is a poorly understood and dangerous medical problem. COVID-19-related pulmonary vessels involvement is a complex set of interrelated pathophysiological processes associated with vascular endothelial dysfunction and accompanied by thrombosis of various localization, vasomotor disorders, severe respiratory failure, as well as pulmonary embolism (PE) resulting in chronic thromboembolic pulmonary hypertension (CTEPH). According to computed tomographic pulmonary angiography, the incidence of PE in patients with COVID-19 ranges from 23 to 30%. The aim of this work was to focus the doctors' attention on the risk of pulmonary hypertension in patients after COVID-19.Despite the ability of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) to infect various organs and systems, the main and most serious complications are pulmonary infiltration, acute respiratory distress syndrome, acute respiratory failure and PE, which in some cases becomes the triggering mechanism for CTEPH development. The literature review presents data on main pathological abnormalities developing in target organs during COVID-19 and playing an important role in increasing the CTEPH risk. The paper describes the main methods of instrumental investigations of CTEPH and an algorithm for its use in COVID-19 survivors.The revealed data demonstrated that the absence of obvious signs of pulmonary hypertension/CTEPH, the cardiopulmonary system abnormalities cannot be ruled out. Therefore, it seems appropriate to actively follow up COVID-19 survivors. A thoroughly, purposefully collected anamnesis, pulmonary function tests and stress echocardiography in an ambiguous clinical situation will play a leading role as they identify cardiopulmonary disorders and provide the doctor with basic information for further planning of patient management.Keywords
This publication has 37 references indexed in Scilit:
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Lung Perfused Blood Volume Images With Dual-Energy Computed Tomography for Chronic Thromboembolic Pulmonary HypertensionJournal of Computer Assisted Tomography, 2011
- Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?The Open Cardiovascular Medicine Journal, 2010
- Don't Bury the V/Q Scan: It's as Good as Multidetector CT Angiograms with a Lot Less Radiation ExposureJournal of Nuclear Medicine, 2007
- Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient miceAtherosclerosis, 2007
- Ventilation-Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary HypertensionJournal of Nuclear Medicine, 2007
- Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertensionThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Pulmonary artery sarcoma masquerading as chronic thromboembolic pulmonary hypertensionNature Clinical Practice Cardiovascular Medicine, 2005
- Perfusion Scan Findings Understate the Severity of Angiographic and Hemodynamic Compromise in Chronic Thromboembolic Pulmonary HypertensionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1988
- Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertensionAmerican Journal of Roentgenology, 1985